CVS Health (NYSE:CVS) Given New $92.00 Price Target at Robert W. Baird

CVS Health (NYSE:CVS) had its target price boosted by stock analysts at Robert W. Baird from $82.00 to $92.00 in a research note issued to investors on Wednesday,Benzinga reports. The firm currently has an “outperform” rating on the pharmacy operator’s stock. Robert W. Baird’s target price points to a potential upside of 17.49% from the company’s previous close.

A number of other equities research analysts have also commented on the company. Zacks Research lowered CVS Health from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 8th. Evercore ISI raised their target price on shares of CVS Health from $85.00 to $95.00 and gave the stock an “outperform” rating in a report on Thursday, October 30th. Sanford C. Bernstein upped their price target on shares of CVS Health from $77.00 to $86.00 and gave the company a “market perform” rating in a report on Thursday, December 4th. Leerink Partners lifted their price target on CVS Health from $86.00 to $95.00 and gave the company an “outperform” rating in a research report on Thursday, October 16th. Finally, The Goldman Sachs Group assumed coverage on shares of CVS Health in a report on Tuesday, October 14th. They set a “buy” rating and a $91.00 target price for the company. Two research analysts have rated the stock with a Strong Buy rating, twenty have issued a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $92.19.

CVS Health Stock Performance

Shares of CVS Health stock opened at $78.31 on Wednesday. The company has a 50 day moving average price of $78.82 and a 200 day moving average price of $71.59. The firm has a market capitalization of $99.41 billion, a P/E ratio of 206.08, a PEG ratio of 0.75 and a beta of 0.48. The company has a quick ratio of 0.63, a current ratio of 0.83 and a debt-to-equity ratio of 0.83. CVS Health has a 52 week low of $43.56 and a 52 week high of $85.15.

CVS Health (NYSE:CVS) last released its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share for the quarter, topping the consensus estimate of $1.36 by $0.24. The company had revenue of $102.87 billion for the quarter, compared to the consensus estimate of $98.85 billion. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. CVS Health’s revenue was up 7.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.09 EPS. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. Sell-side analysts expect that CVS Health will post 5.89 EPS for the current year.

Hedge Funds Weigh In On CVS Health

Hedge funds and other institutional investors have recently modified their holdings of the business. Stone House Investment Management LLC purchased a new stake in shares of CVS Health in the first quarter valued at approximately $39,000. Callan Family Office LLC increased its stake in shares of CVS Health by 59.0% in the 1st quarter. Callan Family Office LLC now owns 32,055 shares of the pharmacy operator’s stock worth $2,172,000 after acquiring an additional 11,890 shares during the last quarter. Resona Asset Management Co. Ltd. raised its holdings in shares of CVS Health by 6.6% during the 1st quarter. Resona Asset Management Co. Ltd. now owns 456,208 shares of the pharmacy operator’s stock worth $30,871,000 after acquiring an additional 28,387 shares during the period. Klingman & Associates LLC acquired a new position in CVS Health in the 1st quarter valued at about $224,000. Finally, National Pension Service increased its holdings in shares of CVS Health by 5.8% during the 1st quarter. National Pension Service now owns 3,152,397 shares of the pharmacy operator’s stock worth $213,575,000 after buying an additional 173,108 shares during the last quarter. 80.66% of the stock is owned by hedge funds and other institutional investors.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.